ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,385.12
0.96%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.775
0.00%
Brent Oil
82.585
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Axonics Inc (AXNX)

  7. Axonics Inc (AXNX) ニュース

AXNX

Axonics (AXNX)

Axonics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AXNX
日付受信時刻ニュースソース見出しコード企業名
2024/05/0105 : 01Business WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
2024/04/2419 : 30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
2024/03/2305 : 01Business WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
2024/03/2205 : 54Business WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
2024/03/1419 : 00Business WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
2024/03/0807 : 24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
2024/03/0106 : 01Business WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
2024/02/2906 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
2024/02/2906 : 01Business WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
2024/02/2222 : 00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
2024/02/0308 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2024/02/0307 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2024/02/0307 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2024/02/0307 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2024/01/3120 : 30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
2024/01/1110 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2024/01/1105 : 07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
2024/01/0907 : 19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
2024/01/0907 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
2024/01/0906 : 55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
2024/01/0901 : 36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
2024/01/0822 : 47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
2024/01/0821 : 41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
2024/01/0821 : 00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
2024/01/0821 : 00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
2024/01/0821 : 00Business WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
2023/12/2909 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
2023/12/2806 : 01Business WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
2023/12/2703 : 31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
2023/11/0702 : 00GlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
 Showing the most relevant articles for your search:NASDAQ:AXNX

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
FX
USDGBP
US Dollar vs Sterling
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
NYSE
AXP
American Express
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
CCOM
US100
US Tech 100
NYSE
MRK
Merck
CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有